Schering-Plough Corporation
2000 Galloping Hill Road
Kenilworth
New Jersey
07033
United States
Tel: 201-822-7000
Fax: 201-822-7447
Website: http://www.sch-plough.com/
509 articles about Schering-Plough Corporation
-
Merck & Co., Inc. (San Francisco) (JOBS) CEO Announces Structure and Global Leadership Team for New Merck; Company to Form 5 Divisions After Schering-Plough Corporation (JOBS) Buyout
9/3/2009
-
Schering-Plough Corporation: New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day
9/1/2009
-
Court Denies Schering-Plough Corporation (JOBS) in $690 Million Tax Case
9/1/2009
-
Schering-Plough Corporation Announces Two European Filings
8/26/2009
-
Biotech 2009 to Feature Schering-Plough Corporation Chairman and CEO as Luncheon Keynote Speaker
8/20/2009
-
Schering-Plough Corporation (JOBS) Announces FDA Approval of SAPHRIS(R) (asenapine) for Acute Treatment of Schizophrenia in Adults and Manic or Mixed Episodes of Bipolar I Disorder
8/14/2009
-
Schering-Plough Corporation Settles Final Clarinex Patent Litigation
8/12/2009
-
Schering-Plough Corporation New CLARITIN(R) Eye Relieves Itchy Eyes For Up To 12 Hours
8/11/2009
-
Bayer AG (JOBS) May Be Ready for Deals After Lost Intervet Bid
8/11/2009
-
Schering-Plough Corporation to Webcast Special Meeting of Shareholders
8/7/2009
-
Merck & Co., Inc. (JOBS) Shareholders OK Schering-Plough Corporation (JOBS) Purchase
8/7/2009
-
Merck & Co., Inc. (JOBS), Schering-Plough Corporation (JOBS) in $41.5 Million Cholesterol Settlement
8/5/2009
-
Schering-Plough Corporation (JOBS) Release: FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia
7/31/2009
-
US FDA Staff--Schering-Plough Corporation (JOBS) Antipsychotic Works
7/28/2009
-
Schering-Plough Corporation's (JOBS) SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia
7/24/2009
-
Schering-Plough Corporation's Hepatitis C Drug Works About The Same As Roche's, Johns Hopkins University Study
7/23/2009
-
Schering-Plough Corporation Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
7/23/2009
-
Schering-Plough Corporation (JOBS) 2nd-Quarter Profit Jumps
7/21/2009
-
Merck & Co., Inc., Schering-Plough Corporation Reach Vytorin Deal with States
7/16/2009
-
Schering-Plough Corporation Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV CCR5 Antagonist Evaluated in Novel Nucleoside-Sparing Regimen Designed to Provide Additional Treatment Options, Preserve other HIV Drugs for Subsequent Use
7/15/2009